DETECTION OF MUTATIONS IN RPOB GENE RESPONSIBLE FOR RIFAMPICIN-RESISTANCE AMONG CLINICAL ISOLATES OF M. TUBERCULOSIS FROM DIFFERENT REGIONS OF KAZAKHSTAN
Spectrum of mutations in rpoB gene that cause resistance to one of the main antituberculosis drugs – rifampicin in clinical isolates of M. tuberculosis distributed in 3 regions (Almaty, Kostanay, Kyzylorda) of Kazakhstan was estimated in this study. High frequency of mutation at codon Ser531 of rpoB gene (79,2%) responsible for drug resistance to rifampicin was determined among M. tuberculosis population circulating in the mentioned regions.
Көрген адамдардың саны: 500
Мақалалар санаты:
Мақалалар
Библиографиялық сілтемелер
А.Ж. Ахметова1, С.Е. Рахимова1, В.Л. Бисмилда2, М.А. Даришева3, А.Р. Акилжанова1 ОПРЕДЕЛЕНИЕ МУТАЦИЙ В RPOB ГЕНЕ, ОБУСЛАВЛИВАЮЩИХ УСТОЙЧИВОСТЬ К РИФАМПИЦИНУ СРЕДИ КЛИНИЧЕСКИХ ИЗОЛЯТОВ M. TUBERCULOSIS ИЗ РАЗЛИЧНЫХ ОБЛАСТЕЙ КАЗАХСТАНА //Наука и Здравоохранение 2014.№ 4. С. 26-27 А.Zh. Аkhmetova1, S.Е. Rakhimova1, V.L. Bismilda2, М.А. Darisheva3, A.R. Akilzhanova1 DETECTION OF MUTATIONS IN RPOB GENE RESPONSIBLE FOR RIFAMPICIN-RESISTANCE AMONG CLINICAL ISOLATES OF M. TUBERCULOSIS FROM DIFFERENT REGIONS OF KAZAKHSTAN // Nauka i Zdravookhranenie. 2014.№ 4. С. 26-27 А.Ж. Ахметова1, С.Е. Рахимова1, В.Л. Бісмілда2, М.А. Даришева3, А.Р. Ақылжанова1 ҚАЗАҚСТАННЫҢ ӘР ТҮРЛІ ОБЛЫСТАРЫНДА ТАРАЛҒАН M. TUBERCULOSIS ИЗОЛЯТТАРЫНЫҢ РИФАМПИЦИНГЕ ТӨЗІМДІЛІГІН АНЫҚТАЙТЫН RPOB ГЕНІНДЕ МУТАЦИЯЛАРДЫ АНЫҚТАУ // Ғылым және Денсаулық сақтау 2014.№ 4. С. 26-27Ұқсас жариялымдар:
INDICATORS OF DAILY MONITORING OF THE BLOOD PRESSURE IN CHILDREN WITH ARTERIAL HYPERTENSION BORN FROM IRRADIATED PARENTS
ANALYSIS OF TRENDS IN THE INCIDENCE OF HOSPITALIZED ACUTE MYOCARDIAL INFARCTION IN SEMEY REGION
RISK FACTORS FOR CERVICAL CANCER IN SEMEY REGION
DETECTION OF MUTATIONS IN RPOB GENE RESPONSIBLE FOR RIFAMPICIN-RESISTANCE AMONG CLINICAL ISOLATES OF M. TUBERCULOSIS FROM DIFFERENT REGIONS OF KAZAKHSTAN
EFFICIENCY OF APPLICATION OF POLARIZED LIGHT AND PREPARATION OF NITROGEN OXIDE DONOR FOR THE PURPOSE OF CORRECTION ENDOTHELIAL DYSFUNCTION AT PATIENTS WITH FIXED ORTHODONTIC TECHNICS